Fingerprint
Dive into the research topics of 'Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically